Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04034927
Title Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

ovarian clear cell carcinoma

ovarian serous carcinoma

mixed epithelial tumor of ovary

endometrioid ovary carcinoma

ovary transitional cell carcinoma

peritoneum cancer

fallopian tube cancer

Therapies

Olaparib

Olaparib + Tremelimumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
Hartford Hospital Hartford Connecticut 06102 United States Details
Augusta University Medical Center Augusta Georgia 30912 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
University of New Mexico Cancer Center Albuquerque New Mexico 87102 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
UHHS-Chagrin Highlands Medical Center Beachwood Ohio 44122 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
Women and Infants Hospital Providence Rhode Island 02905 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field